A Study Following Males With Haemophilia B on Prophylaxis With Refixia/REBINYN
Clinical trial NCT03745924 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT03745924
- Sponsor
- Novo Nordisk A/S
- Status
- ENROLLING_BY_INVITATION
- Study type
- OBSERVATIONAL
- Start date
- 2019-04-01
- Primary completion
- 2027-12-15
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.